the National Institute for Health and Care Excellence guidelines are developed for decision-making on clinical care and funding of services in the UK. 5 Evidence-based studies have been used by insurance companies 6 and clinical commissioning groups 7 to direct the funding of care.
The quality of evidence depends on the methodology of the study, particularly with regard to controlling for bias and confounding factors. Lowquality studies include case series or historically controlled comparative studies; valid conclusions about the relative effectiveness of one intervention over another cannot be drawn. Double-blind randomised controlled trials that limit the effects of bias and confounding factors are gold standard.
A systematic review or meta-analysis of multiple randomised controlled trials provides more robust evidence.
This study compared the level of evidence of orthopaedic studies published in 2002 and 2012 to determine whether the quality and quantity of studies have increased.
Materials and Methods
The top 10 orthopaedic journals in 2002 and 2012 were identified, according to the Thomson Reuters impact factor ( (Table 2) . 8 Level 1 evidence is of highest quality and level 4 evidence is of lowest quality. Any disagreement was resolved by discussion. Basic science articles, case reports, and non-systematic reviews were excluded. The proportions of papers designated to each level of evidence in 2002 and 2012 were compared using the 2-proportion Z test. The mean level of evidence of studies in 2002 and 2012 was compared using the Mann-Whitney U test.
results
In 2002, 379 clinical articles were identified and their level of evidence was level 1 (n=3), level 2 (n=67), level 3 (n=71), and level 4 (n=238). In 2012, 642 clinical articles were identified and their level of evidence was level 1 (n=26), level 2 (n=113), level 3 (n=167), and level 4 (n=336). The proportion of level 4 articles decreased from 62.8% in 2002 to 52.3% in 2012 (p=0.001), whereas the proportion of level 1 articles increased from 0.8% to 4.1% (p=0.002) and level 3 articles increased from 18.7% to 26.0% (p=0.008) [ Table 3 ]. The mean level of evidence improved from 3.44 in 2002 to 3.27 in 2012 (p=0.002).
discussion
Evidence-based medicine does not necessarily mean high-quality evidence. Rather, it means that the best available resources are used to make healthcarerelated decisions. The scientific quality of articles published in the top 10 orthopaedic journals has improved from 2002 to 2012. The proportion of level 1 and level 3 articles and the total number of articles increased during the 10 years. The number of welldesigned, randomised controlled trials (level 1 and level 2 evidence) in orthopaedics is insufficient. [9] [10] [11] Case series and retrospectively controlled studies (level 4 evidence) remain the most common studies and are a major source of evidence to direct decisionmaking (without randomised controlled trials to confirm findings). Case series can provide evidence relatively quickly and cheaply, but lack control for bias and confounding factors.
Registries for joint replacements and knee ligament reconstruction are useful for long-term surveillance of devices and techniques. 12 Registries provide an overview of current trends and identify variables that affect outcome, but randomised controlled trials are more effective in determining optimum assessment and management. Registries and randomised controlled trials provide different types of information.
Randomised controlled trials are the gold standard to assess the efficacy and effectiveness of an intervention, [13] [14] [15] but have difficulties in assessing surgeon preference, patient preference, and the quality control of trial interventions. 13, 14 Randomised controlled trials necessitate greater administration and ethical scrutiny, resulting in increased human and financial resources. Nevertheless, a well-designed randomised controlled trial elicits more reliable information than historically controlled studies or case series. 16 Observational studies remain popular. 17 Systematic review and meta-analysis of randomised controlled trials provides level 1 evidence, although many systematic reviews use data from non-randomised trials with a low level of evidence. The increase in the number of overall studies and the proportion of studies with higher levels of evidence improved the quality of the evidence.
There are limitations to this study. The top 10 impact factor journals for year 2002 and 2012 were used (rather than the same 10 journals); this avoids inclusion of journals that have ceased publication, reflects changes in the relative importance of journals, and enables inclusion of new journals. Impact factors are a measure of citations and not a measure of quality. Journals with greater print or online availability are more likely to be cited. In addition, many high-quality studies not in the top 10 journals were excluded, as were studies published in general medical or surgical journals. The criteria for the levels of evidence were published in 2011. Research papers published in 2012 were probably more in line with the criteria and hence of 'better' quality, whereas papers published in 2002 may have been less compliant with the criteria, as the criteria were less well-established at that time. 
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